These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 38793700)

  • 1. Polymeric Caffeic Acid Acts as an Antigen Delivery Carrier for Mucosal Vaccine Formulation by Forming a Complex with an Antigenic Protein.
    Tada R; Nagai Y; Ogasawara M; Saito M; Ohshima A; Yamanaka D; Kunisawa J; Adachi Y; Negishi Y
    Vaccines (Basel); 2024 Apr; 12(5):. PubMed ID: 38793700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymeric Caffeic Acid Acts as a Nasal Vaccine Formulation against
    Tada R; Suzuki H; Ogasawara M; Yamanaka D; Adachi Y; Kunisawa J; Negishi Y
    Pharmaceutics; 2021 Apr; 13(4):. PubMed ID: 33923897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymeric Caffeic Acid Is a Safer Mucosal Adjuvant That Augments Antigen-Specific Mucosal and Systemic Immune Responses in Mice.
    Tada R; Yamanaka D; Ogasawara M; Saito M; Ohno N; Kiyono H; Kunisawa J; Aramaki Y
    Mol Pharm; 2018 Sep; 15(9):4226-4234. PubMed ID: 30107747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intranasal administration of sodium nitroprusside augments antigen-specific mucosal and systemic antibody production in mice.
    Tada R; Yamazaki H; Nagai Y; Takeda Y; Ohshima A; Kunisawa J; Negishi Y
    Int Immunopharmacol; 2023 Jun; 119():110262. PubMed ID: 37150015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enzymatically polymerised polyphenols prepared from various precursors potentiate antigen-specific immune responses in both mucosal and systemic compartments in mice.
    Tada R; Ogasawara M; Yamanaka D; Sakurai Y; Negishi Y; Kiyono H; Ohno N; Kunisawa J; Aramaki Y
    PLoS One; 2021; 16(2):e0246422. PubMed ID: 33556119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Systemic and Mucosal Immune Responses Induced by a Nasal Powder Delivery System in Conjunction with an OVA Antigen in Cynomolgus Monkeys.
    Torikai Y; Sasaki Y; Sasaki K; Kyuno A; Haruta S; Tanimoto A
    J Pharm Sci; 2021 May; 110(5):2038-2046. PubMed ID: 33278410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity of Antigen Adjuvanted with AS04 and Its Deposition in the Upper Respiratory Tract after Intranasal Administration.
    Xu H; Alzhrani RF; Warnken ZN; Thakkar SG; Zeng M; Smyth HDC; Williams RO; Cui Z
    Mol Pharm; 2020 Sep; 17(9):3259-3269. PubMed ID: 32787271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucosal and systemic immune responses by intranasal immunization using archaeal lipid-adjuvanted vaccines.
    Patel GB; Zhou H; Ponce A; Chen W
    Vaccine; 2007 Dec; 25(51):8622-36. PubMed ID: 17959279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of interleukin-6 in antigen-specific mucosal immunoglobulin A induction by cationic liposomes.
    Tada R; Hidaka A; Tanazawa Y; Ohmi A; Muto S; Ogasawara M; Saito M; Ohshima A; Iwase N; Honjo E; Kiyono H; Kunisawa J; Negishi Y
    Int Immunopharmacol; 2021 Dec; 101(Pt A):108280. PubMed ID: 34710845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intranasal Immunization with DOTAP Cationic Liposomes Combined with DC-Cholesterol Induces Potent Antigen-Specific Mucosal and Systemic Immune Responses in Mice.
    Tada R; Hidaka A; Iwase N; Takahashi S; Yamakita Y; Iwata T; Muto S; Sato E; Takayama N; Honjo E; Kiyono H; Kunisawa J; Aramaki Y
    PLoS One; 2015; 10(10):e0139785. PubMed ID: 26440657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surface assembly of poly(I:C) on polyethyleneimine-modified gelatin nanoparticles as immunostimulatory carriers for mucosal antigen delivery.
    Lin SF; Jiang PL; Tsai JS; Huang YY; Lin SY; Lin JH; Liu DZ
    J Biomed Mater Res B Appl Biomater; 2019 May; 107(4):1228-1237. PubMed ID: 30339742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intranasal immunization with curdlan induce Th17 responses and enhance protection against enterovirus 71.
    Yi EJ; Kim YI; Song JH; Ko HJ; Chang SY
    Vaccine; 2023 Mar; 41(13):2243-2252. PubMed ID: 36863926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attachment of class B CpG ODN onto DOTAP/DC-chol liposome in nasal vaccine formulations augments antigen-specific immune responses in mice.
    Tada R; Muto S; Iwata T; Hidaka A; Kiyono H; Kunisawa J; Aramaki Y
    BMC Res Notes; 2017 Jan; 10(1):68. PubMed ID: 28126014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intranasal Vaccination With Recombinant Antigen-FLIPr Fusion Protein Alone Induces Long-Lasting Systemic Antibody Responses and Broad T Cell Responses.
    Hsieh MS; Hsu CW; Tu LL; Chai KM; Yu LL; Wu CC; Chen MY; Chiang CY; Liu SJ; Liao CL; Chen HW
    Front Immunol; 2021; 12():751883. PubMed ID: 34707615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential of Translationally Controlled Tumor Protein-Derived Protein Transduction Domains as Antigen Carriers for Nasal Vaccine Delivery.
    Bae HD; Lee J; Jin XH; Lee K
    Mol Pharm; 2016 Sep; 13(9):3196-205. PubMed ID: 27454469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formulation and characterization of nanoemulsion intranasal adjuvants: effects of surfactant composition on mucoadhesion and immunogenicity.
    Wong PT; Wang SH; Ciotti S; Makidon PE; Smith DM; Fan Y; Schuler CF; Baker JR
    Mol Pharm; 2014 Feb; 11(2):531-44. PubMed ID: 24320221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nasal Flt3 ligand cDNA elicits CD11c+CD8+ dendritic cells for enhanced mucosal immunity.
    Kataoka K; McGhee JR; Kobayashi R; Fujihashi K; Shizukuishi S; Fujihashi K
    J Immunol; 2004 Mar; 172(6):3612-9. PubMed ID: 15004163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipopolysaccharide Derived From the Lymphoid-Resident Commensal Bacteria
    Wang Y; Hosomi K; Shimoyama A; Yoshii K; Nagatake T; Fujimoto Y; Kiyono H; Fukase K; Kunisawa J
    Front Immunol; 2021; 12():699349. PubMed ID: 34276692
    [No Abstract]   [Full Text] [Related]  

  • 19. Mucosal adjuvant properties of the Shigella invasin complex.
    Kaminski RW; Turbyfill KR; Oaks EV
    Infect Immun; 2006 May; 74(5):2856-66. PubMed ID: 16622224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimization of mucosal responses after intramuscular immunization with integrase defective lentiviral vector.
    Rossi A; Michelini Z; Leone P; Borghi M; Blasi M; Bona R; Spada M; Grasso F; Gugliotta A; Klotman ME; Cara A; Negri D
    PLoS One; 2014; 9(9):e107377. PubMed ID: 25210766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.